Oct
2026
Fiera Milano, Italy
Visit us
stand 20C77, Finished Dosage & Formulation

Gelesis srl

Exhibitor at CPHI Milan 2026
About Us

Gelesis,is an innovative italian biotech company working to improve lives of people struggling with excess in weight and metabolic diseases through its Breakthrough Platform.

Gelesis has a CE & FDA-Cleared manufacturing of oral Medical Devices for overweight and obesity with an unprecedent combination of efficacy and safety due to a novel biomimetic approach. Its technologies are backed with solid pre-clinical and clinical evidence and an ambitious clinical plan on-going as well as a highly promising pipeline.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2026
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Pharmaceutical company
Primary activities
Biopharmaceutical
Medical Devices
OTC
Other
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20C77, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Plenity

    Product Plenity

    FDA-CE cleared novel oral treatment for overweight and obesity that has an unprecedented efficacy and safety profile.

    Plenity is a non-systemic medical device that complements pharmacological obesity treatments by enabling early intervention, supporting weight trajectory stabilization after syst...

Gelesis srl Resources (1)

  • Gelesis Corporate Presentation

    Brochure Gelesis Corporate Presentation

    In this file you'll know about Gelesis and its patented platform for metabolic disease treatments, its technologies and pipeline. You will enter in the world of Plenity, an innovative oral, biomimetic medical device with unparalled safety and effectiveness profile.